Adjuvant trastuzumab for 6 months is effective in patients with HER2-positive stage II or III breast cancer
Cheng Jeng Tai, Chin Kwun Pan, Ching Shyang Chen, Chin Sheng Hung, Chih Hsiung Wu, Hung Yi Chiou
研究成果: 雜誌貢獻 › 文章 › 同行評審
7
引文
斯高帕斯（Scopus）